Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3771113014 | Lamivudine and nevirapine and stavudine only product in oromucosal dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3771114015 | Product containing only lamivudine and nevirapine and stavudine in oromucosal dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only lamivudine and nevirapine and stavudine in oromucosal dose form (medicinal product form) | Is a | Product containing lamivudine and nevirapine and stavudine in oromucosal dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only lamivudine and nevirapine and stavudine in oromucosal dose form (medicinal product form) | Count of base of active ingredient | 3 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing only lamivudine and nevirapine and stavudine in oromucosal dose form (medicinal product form) | Has manufactured dose form | Oromucosal dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only lamivudine and nevirapine and stavudine in oromucosal dose form (medicinal product form) | Is a | Product containing only lamivudine and nevirapine and stavudine (medicinal product) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only lamivudine and nevirapine and stavudine in oromucosal dose form (medicinal product form) | Has active ingredient | Lamivudine | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing only lamivudine and nevirapine and stavudine in oromucosal dose form (medicinal product form) | Has active ingredient | Nevirapine | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing only lamivudine and nevirapine and stavudine in oromucosal dose form (medicinal product form) | Has active ingredient | Stavudine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing only lamivudine and nevirapine and stavudine in oromucosal dose form (medicinal product form) | Plays role | Antiretroviral therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) | Is a | False | Product containing only lamivudine and nevirapine and stavudine in oromucosal dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
| Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Is a | False | Product containing only lamivudine and nevirapine and stavudine in oromucosal dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR